Cargando…
Targeting Nutrient Dependency in Cancer Treatment
Metabolic reprogramming is one of the hallmarks of tumor. Growing evidence suggests metabolic changes that support oncogenic progression may cause selective vulnerabilities that can be exploited for cancer treatment. Increasing demands for certain nutrients under genetic determination or environment...
Autores principales: | Fan, Kexin, Liu, Zhan, Gao, Min, Tu, Kangsheng, Xu, Qiuran, Zhang, Yilei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846368/ https://www.ncbi.nlm.nih.gov/pubmed/35178349 http://dx.doi.org/10.3389/fonc.2022.820173 |
Ejemplares similares
-
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022) -
Copper in cancer: from limiting nutrient to therapeutic target
por: Tang, Xiaolong, et al.
Publicado: (2023) -
Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
por: Zeng, Zhi, et al.
Publicado: (2021) -
Metal-Organic Frameworks and Their Composites Towards Biomedical Applications
por: Ma, Yana, et al.
Publicado: (2021) -
Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression
por: Liu, Zhikui, et al.
Publicado: (2021)